In the BioHarmony Drug Report Database

"Preview" Icon

Hydroxocobalamin

Cyanokit (hydroxocobalamin) is a small molecule pharmaceutical. Hydroxocobalamin was first approved as Cyanokit on 2006-12-15. It is used to treat alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, and poisoning in the USA. It has been approved in Europe to treat poisoning.

 

Trade Name

 

Cyanokit
 

Common Name

 

hydroxocobalamin
 

ChEMBL ID

 

CHEMBL2103737
 

Indication

 

alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, poisoning
 

Drug Class

 

Image (chem structure or protein)

Hydroxocobalamin structure rendering